Aeglea Biotherapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.4M | 501k | 16.76 |
| 2025-06-30 | $7.3M | 489k | 14.97 |
| 2025-03-31 | $7.9M | 489k | 16.14 |
| 2024-12-31 | $11M | 449k | 23.28 |
| 2024-09-30 | $8.6M | 293k | 29.41 |
| 2024-06-30 | $6.9M | 293k | 23.51 |
| 2024-03-31 | $758k | 20k | 37.93 |
| 2023-12-31 | $430k | 20k | 21.52 |